USEUROPEAFRICAASIA 中文双语Français
Home / Business

Medical M&A deals abroad to continue

By Meng Fanbin | China Daily | Updated: 2017-08-04 09:14

Deloitte report downplays the impact of capital outflow controls on healthcare

Despite recent controls on capital outflows, Chinese healthcare and life science companies will continue to find ample opportunities for mergers and acquisitions or M&A abroad, according to a report by Deloitte Touche Tohmatsu, one of the "Big Four" global accounting firms.

The recent slowdown in health-related M&A notwithstanding, Chinese overseas investments will accelerate, especially in medical equipment and related services, given the inadequate research and development capabilities at home, expectations of the renminbi's depreciation and overvalued domestic M&A targets, said the DTT report.

Medical M&A deals abroad to continue

Today's Top News

Editor's picks

Most Viewed

Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US